| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Achieve Life Sciences, Inc. (ACHV) has 14 insiders with recent SEC Form 4 filings, including 6 buys and 35 sells. ACHV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.80M | $8.93M | - | |
| Dir | 315.1K | $1.56M | - | |
| Other | 250.0K | $1.24M | - | |
| Pres | 143.2K | $710.3K | - | |
| CFO | 127.9K | $634.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | Bencich John45 | CEO | Buy | 5,000 | $5.50 | $27,500.00 | +8.1% | -27.1% | -14.4% | |
| Nov 18, 2022 | Bencich John45 | CEO | Buy | 22,000 | $0.00 | - | +147.5% | +126.4% | +121.8% | |
| May 27, 2021 | Bencich John45 | CEO | Buy | 6,000 | $7.00 | $42,000.00 | +4,255% | -1.5% | -12.0% | |
| Jun 11, 2019 | Armistice Capital, LLC56 | 10% Owner | Sell | 47,182 | $2.86 | $134,820.70 | -1.4% | - | - | |
| Jun 11, 2019 | Armistice Capital, LLC56 | 10% Owner | Sell | 264,963 | $3.16 | $837,467.28 | -1.0% | - | - | |
| Jun 11, 2019 | Armistice Capital, LLC56 | 10% Owner | Buy | 12,813 | $3.80 | $48,689.40 | +0.6% | - | - | |
| May 23, 2019 | Stewart Richard Alistair48 | Chairman &CEO | Buy | 17,500 | $3.61 | $63,092.75 | +9.0% | - | - | |
| Aug 19, 2016 | Bencich John45 | CFO | Sale+OE | 1,380 | $0.57 | $786.60 | -12.7% | - | - | |
| Jun 13, 2016 | Jacobs Cindy | EVP, CMO | Sale+OE | 1,437 | $1.03 | $1,473.50 | -1.8% | - | - | |
| Jun 13, 2016 | Cormack Scott Daniel | President And CEO | Sale+OE | 4,856 | $1.03 | $4,979.34 | -3.6% | - | - |